Literature DB >> 2877172

Identification of HLA-Dw14 genes in DR4+ rheumatoid arthritis.

G T Nepom, C E Seyfried, S L Holbeck, K R Wilske, B S Nepom.   

Abstract

Genes of the major histocompatibility complex, HLA, are associated with susceptibility to rheumatoid arthritis (RA), but the aetiology of this chronic inflammatory disease is not known. Synthetic oligonucleotide DNA probes were constructed to distinguish between two closely related but distinct alleles encoding the HLA-DR4 specificity in patients with RA. With these allele-specific oligonucleotide probes an uncommon DR4 genetic variant, Dw14, was identified in 6 of 7 RA patients homozygous for HLA-DR4. This allele may play an important part in susceptibility to RA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877172     DOI: 10.1016/s0140-6736(86)92614-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  30 in total

Review 1.  The immunogenetics of rheumatoid arthritis.

Authors:  B P Wordsworth; J I Bell
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Evolution of HLA class-II genes and haplotypes.

Authors:  J Silver
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 3.  T cell receptor genes in rheumatoid arthritis.

Authors:  J P Dutz; A Chan; T Mak; K A Siminovitch; L A Rubin
Journal:  Springer Semin Immunopathol       Date:  1989

Review 4.  Structural variation among major histocompatibility complex class-II genes which predispose to autoimmunity.

Authors:  G T Nepom
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 5.  The molecular basis of susceptibility to rheumatoid arthritis: the conformational equivalence hypothesis.

Authors:  R J Winchester; P K Gregersen
Journal:  Springer Semin Immunopathol       Date:  1988

6.  Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis.

Authors:  J J Goronzy; P Bartz-Bazzanella; W Hu; M C Jendro; D R Walser-Kuntz; C M Weyand
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Differences in HLA antigens between patients with mixed connective tissue disease and systemic lupus erythematosus.

Authors:  P Ruuska; R Hämeenkorpi; S Forsberg; H Julkunen; R Mäkitalo; J Ilonen; A Tiilikainen
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

Review 8.  New perspectives of secondary and tertiary therapy for rheumatoid arthritis.

Authors:  R F Willkens
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

9.  Molecular analysis of HLA-DR beta and DQ beta polymorphism in Chinese with rheumatoid arthritis.

Authors:  J Molkentin; P K Gregersen; X Lin; N Zhu; Y Wang; Y Wang; S Chen; S Chen; L A Baxter-Lowe; J Silver
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

10.  Share epitope, citrullinated cyclic peptide antibodies and smoking in Brazilian rheumatoid arthritis patients.

Authors:  Rene Donizeti Oliveira; Cristina Maria Junta; Fabíola Reis Oliveira; Lucienir Maria Silva; Eduardo Antonio Donadi; Paulo Louzada-Junior
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.